date:Aug 13, 2014
related to our medical biomaterials business.
Shareholders' equity in the first half-year increased by 1.0 million to 506.2 million. The movements were:
The addition of the positive result after taxes of 0.4 million;
A decrease of 5.6 million related to the dividend for financial year 2013;
Positive exchange rate differences of 4.4 million due to the translation of equity denominated in currencies other than the euro;
Share based remuneration impact of 2.0 million;
Positive movement